LABORATORIO ELEA PHOENIX S.A.
Clinical Trials
17
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
- Conditions
- Parkinson Disease
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 88
- Registration Number
- NCT06629389
- Locations
- 🇦🇷
Hospital Español de Mendoza, Mendoza, Argentina
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
- Conditions
- Non Small Cell Lung Cancer Metastatic
- Interventions
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 174
- Registration Number
- NCT05668650
- Locations
- 🇦🇷
Clínica Viedma, Viedma, Río Negro, Argentina
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
- Conditions
- Chagas Disease
- Interventions
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 300
- Registration Number
- NCT04897516
- Locations
- 🇦🇷
Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben", Buenos Aires, Argentina
🇦🇷Fundación Huésped, Buenos Aires, Argentina
🇦🇷Hospital Francisco Javier Muñiz, Buenos Aires, Argentina
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
- Conditions
- COVID-19 Virus Infection
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 3000
- Registration Number
- NCT04560881
- Locations
- 🇦🇷
Fundación Huésped, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
🇦🇷Vacunar Liniers, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
🇦🇷Vacunar Cañitas, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19
- Conditions
- COVID-19 Drug Treatment
- Interventions
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Laboratorio Elea Phoenix S.A.
- Target Recruit Count
- 45
- Registration Number
- NCT04381884
- Locations
- 🇦🇷
Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina
🇦🇷Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" CEMIC, Buenos Aires, Ciudad De Buenos Aires, Argentina
🇦🇷Hospital de Infecciosas Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aires, Argentina
- Prev
- 1
- 2
- 3
- 4
- Next